PT2483274E - Agentes antimaláricos que são inibidores de di-hidro-orotato desidrogenase - Google Patents

Agentes antimaláricos que são inibidores de di-hidro-orotato desidrogenase Download PDF

Info

Publication number
PT2483274E
PT2483274E PT108211053T PT10821105T PT2483274E PT 2483274 E PT2483274 E PT 2483274E PT 108211053 T PT108211053 T PT 108211053T PT 10821105 T PT10821105 T PT 10821105T PT 2483274 E PT2483274 E PT 2483274E
Authority
PT
Portugal
Prior art keywords
inhibitors
dihydroorotate dehydrogenase
antimalarial agents
antimalarial
agents
Prior art date
Application number
PT108211053T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Univ Texas
Univ Washington
Univ Monash
Glaxosmithkline Investigacion Y Desarrollo S L
Medicines For Malaria Venture Mmv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Univ Washington, Univ Monash, Glaxosmithkline Investigacion Y Desarrollo S L, Medicines For Malaria Venture Mmv filed Critical Univ Texas
Publication of PT2483274E publication Critical patent/PT2483274E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT108211053T 2009-09-29 2010-09-28 Agentes antimaláricos que são inibidores de di-hidro-orotato desidrogenase PT2483274E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24686309P 2009-09-29 2009-09-29

Publications (1)

Publication Number Publication Date
PT2483274E true PT2483274E (pt) 2015-02-04

Family

ID=43826848

Family Applications (1)

Application Number Title Priority Date Filing Date
PT108211053T PT2483274E (pt) 2009-09-29 2010-09-28 Agentes antimaláricos que são inibidores de di-hidro-orotato desidrogenase

Country Status (15)

Country Link
US (1) US9238653B2 (enExample)
EP (1) EP2483274B1 (enExample)
JP (1) JP5818266B2 (enExample)
CN (1) CN102741255B (enExample)
BR (1) BR112012007179B8 (enExample)
CA (1) CA2775354C (enExample)
DK (1) DK2483274T3 (enExample)
ES (1) ES2527835T3 (enExample)
HR (1) HRP20150066T1 (enExample)
ME (1) ME02020B (enExample)
PL (1) PL2483274T3 (enExample)
PT (1) PT2483274E (enExample)
SI (1) SI2483274T1 (enExample)
SM (1) SMT201500071B (enExample)
WO (1) WO2011041304A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6392352B2 (ja) * 2013-12-19 2018-09-19 ノバルティス アーゲー リーシュマニア症などの寄生虫病を処置するための原生動物のプロテアソーム阻害剤としての[1,2,4]トリアゾロ[1,5−a]ピリミジン誘導体
EP3072894A1 (en) 2015-03-26 2016-09-28 Board Of Regents Of the University Of Texas System New substituted triazolopyrimidines as anti-malarial agents
EP3254679A1 (de) 2016-06-09 2017-12-13 Christian-Albrechts-Universität zu Kiel Wirkstoffe gegen protozoen und bakterien
WO2018071282A1 (en) * 2016-10-12 2018-04-19 Merck Sharp & Dohme Corp. Kdm5 inhibitors
EP3548035A4 (en) 2016-11-30 2020-07-22 Case Western Reserve University COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES
CN110573154A (zh) 2017-02-06 2019-12-13 卡斯西部储备大学 调节短链脱氢酶活性的组合物和方法
JP7178360B2 (ja) 2017-04-07 2022-11-25 ケース ウエスタン リザーブ ユニバーシティ 冠状動脈障害を治療するための短鎖型デヒドロゲナーゼ活性の阻害剤
WO2020106998A1 (en) 2018-11-21 2020-05-28 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
EP3842100A1 (en) * 2019-12-24 2021-06-30 The Board Of Regents Of The University Of Texas System Anti-malarial agents
AU2021224268A1 (en) 2020-02-21 2022-09-15 Case Western Reserve University Compositions and methods for treating renal injury

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208693B (en) * 1991-02-22 1993-12-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 1,2,4-triazolo (1,5-a) pyrimidinis derivatives and their carbicycli-tetrahydro-thiofurane-tetrahydrothiopyrane-, or tetrahydropyridine- condensated derivatives or medical preparatives containing them
US5478825A (en) 1991-02-22 1995-12-26 Egis Gyogyszergyar 5-(substituted amino)-1,2,4-triazolo (1,5-A) pyrimidine derivatives
US8490825B2 (en) 1999-12-08 2013-07-23 Metal Container Corporation Can lid closure and method of joining a can lid closure to a can body
CZ294535B6 (cs) * 2001-08-02 2005-01-12 Ústav Experimentální Botaniky Avčr Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
WO2007149211A1 (en) * 2006-06-22 2007-12-27 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
CA2676138A1 (en) * 2007-01-26 2008-08-07 Irm Llc Compounds and compositions as kinase inhibitors
WO2009082691A1 (en) 2007-12-21 2009-07-02 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

Also Published As

Publication number Publication date
HK1174639A1 (en) 2013-06-14
PL2483274T3 (pl) 2015-04-30
CN102741255A (zh) 2012-10-17
CA2775354A1 (en) 2011-04-07
BR112012007179A8 (pt) 2018-01-23
WO2011041304A3 (en) 2011-08-04
US20120302586A1 (en) 2012-11-29
CA2775354C (en) 2019-01-15
EP2483274A4 (en) 2013-03-06
WO2011041304A2 (en) 2011-04-07
SMT201500071B (it) 2015-05-05
BR112012007179B1 (pt) 2020-12-01
SI2483274T1 (sl) 2015-02-27
BR112012007179B8 (pt) 2021-05-25
BR112012007179A2 (pt) 2017-07-25
ME02020B (me) 2015-05-20
DK2483274T3 (en) 2015-01-19
EP2483274A2 (en) 2012-08-08
JP2013506004A (ja) 2013-02-21
US9238653B2 (en) 2016-01-19
ES2527835T3 (es) 2015-01-30
JP5818266B2 (ja) 2015-11-18
HRP20150066T1 (hr) 2015-02-27
CN102741255B (zh) 2015-10-07
EP2483274B1 (en) 2014-10-29

Similar Documents

Publication Publication Date Title
SG10201401169QA (en) Dihydroorotate dehydrogenase inhibitors
SI2483274T1 (sl) Sredstva proti malariji, ki so inhibitorji dihidroorotat dehidrogenaze
ZA201206424B (en) Inhibitors of semicarabazide-sensitive amine oxidase
ZA201700326B (en) Inhibitors of beta-secretase
EP2678018A4 (en) COMBINATION OF CHINESE HEMMER AND USES THEREOF
ZA201000318B (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
IL220956A (en) Inhibitors of s-nitrosoglutathione reductase
ZA201307331B (en) Herbicidal composition comprising plazasulfuron and an inhibitor of protoporphyrinogen oxidase
IL199727A0 (en) Inhibitors of mek
SMT201900320T1 (it) Inibitori dell'arginasi e metodi di utilizzo
ZA201206456B (en) Uses of dgati inhibitors
GB201004179D0 (en) Enzyme inhibitors
GB201004178D0 (en) Enzyme inhibitors
ZA201104146B (en) Dispersions comprising inhibitors of the hydroxyphenylpyruvate-dioxygenase
SG11201401949YA (en) Nadph oxidase 4 inhibitors and use thereof
SG10201404913QA (en) Inhibitors of cognitive decline
IL217833A0 (en) Inhibitors of cognitive decline
ZA201303042B (en) Inhibitors of apoptosis and uses thereof
EP2635287A4 (en) NEDD8 ACTIVATOR ENZYME INHIBITOR ADMINISTRATION
IL217756A0 (en) Inhibitors of jnk
EP2616057A4 (en) COMBINATION OF B-RAF AND VEGFR INHIBITORS
IL208916A0 (en) Inhibitors of jnk
SI2411376T1 (sl) INHIBITORJI NF-kB
IL215486A0 (en) Compositions of cholinesterase inhibitors
LU91725B1 (en) Novel uses of V-ATPASE inhibitors